In the bright stars of the Southeast Asian pharmaceutical market, Indonesia is unique with its huge pharmaceutical intermediates market. As the largest pharmaceutical market in Southeast Asia, Indonesia is also an important base for the global production and export of pharmaceutical intermediates. In 2023, the Indonesian pharmaceutical intermediates market size has reached about $2 billion and is expected to continue to grow rapidly in the next few years.

Indonesia's import volume of pharmaceutical intermediates has continued to grow over the past five years, reaching about $1 billion in 2023. The rapid growth of this market is driven by several key factors:

Booming domestic pharmaceutical industry: Indonesia's domestic pharmaceutical industry has developed rapidly in recent years, and the demand for pharmaceutical intermediates is growing.

Strategic shift of the global pharmaceutical industry: With the shift of the global pharmaceutical industry to Asia, Indonesia, with its cost advantages and labor resources advantages, has attracted more and more foreign enterprises to invest in the production of pharmaceutical intermediates.

Government policy support: The Indonesian government has introduced a series of policies to support the development of the pharmaceutical industry, including tax incentives and financial subsidies, which provide strong support for the development of the pharmaceutical intermediates market.